Article info

Download PDFPDF

Short report
Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study

Authors

  • Haseeb Chaudhary Department of Rheumatology, Case Western Reserve University, University Hospitals, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles
  • Clementina López-Medina Rheumatology, Reina Sofia University Hospital, IMIBIC, Univerisity of Cordoba, Cordoba, SpainDepartment of Rheumatology, Hôpital Cochin. Assistance Publique - Hôpitaux de ParisINSERM (U1153): Clinical epidemiology and biostatistics PRES Sorbonne Paris-Cité, Université de Paris, Paris, France PubMed articlesGoogle scholar articles
  • Muhammad Asim Khan Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles
  • Maxime Dougados Hopital Cochin, Rheumatology, Université Paris Descartes Faculté de Médecine, Paris, France PubMed articlesGoogle scholar articles
  • Marina Magrey Department of Rheumatology, Case Western Reserve University, University Hospitals, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Haseeb Chaudhary; chaudharyhaseebahmad{at}gmail.com
View Full Text

Citation

Chaudhary H, López-Medina C, Khan MA, et al
Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study

Publication history

  • Received March 21, 2023
  • Accepted June 22, 2023
  • First published July 25, 2023.
Online issue publication 
July 25, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.